Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer

被引：38

作者：

Price, CP

Allard, J

Davies, G

Dawnay, A

Duffy, MJ

France, M

Mandarino, G

Ward, AM

Patel, B

Sibley, P

Sturgeon, C

机构：

[1] St Bartholomews & Royal London Sch Med & Dent, Dept Clin Biochem, London E1 2AD, England

[2] Bayer Grp Diagnost, Tarrytown, NY 10591 USA

[3] Wrexham Maelor Hosp, Dept Biochem Med, Wrexham LL13 7TD, Clwyd, Wales

[4] Barts & London NHS Trust, Dept Clin Biochem, London EC1A 7BE, England

[5] St Vincents Hosp, Dept Nucl Med, Dublin 4, Ireland

[6] Manchester Royal Infirm, Dept Chem Pathol, Manchester M13 9WL, Lancs, England

[7] Abbott Labs, Abbott Pk, IL 60064 USA

[8] No Gen Hosp NHS Trust, Dept Immunol, Sheffield S5 7YT, S Yorkshire, England

[9] Euro DPC Ltd, Llanberis LL55 4EL, Caerns, Wales

[10] Royal Infirm, Dept Clin Biochem, Edinburgh EH3 9YW, Midlothian, Scotland

来源：

ANNALS OF CLINICAL BIOCHEMISTRY | 2001年 / 38卷

关键词：

D O I：

10.1258/0004563011900632

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：188 / 216

页数：29

共 158 条

[1]

ABLIN RJ, 1970, J REPROD FERTIL, V22, P573

[2] Prostate specific antigen is metabolized in the liver [J].

Agha, AH ;

Schechter, E ;

Roy, JB ;

Culkin, DJ .

JOURNAL OF UROLOGY, 1996, 155 (04) :1332-1335

[3] RELATIONSHIP BETWEEN DIURNAL RHYTHM OF SERUM TESTOSTERONE AND 2 PROSTATIC MARKERS (PSA AND PAP) IN UNTREATED PROSTATE-CANCER [J].

AKIMOTO, S ;

MASAI, M ;

SHIMAZAKI, J .

UROLOGY, 1994, 43 (03) :337-341

[4]

Allard WJ, 1998, CLIN CHEM, V44, P1216

[5] AGE-SPECIFIC REFERENCE RANGES FOR SERUM PROSTATE-SPECIFIC ANTIGEN [J].

ANDERSON, JR ;

STRICKLAND, D ;

CORBIN, D ;

BYRNES, JA ;

ZWEIBACK, E .

UROLOGY, 1995, 46 (01) :54-57

[6] Stability of serum total and free prostate specific antigen under varying storage intervals and temperature [J].

Arcangeli, CG ;

Smith, DS ;

Ratliff, TL ;

Catalona, WJ .

JOURNAL OF UROLOGY, 1997, 158 (06) :2182-2187

[7]

Arik N., 1996, International Urology and Nephrology, V28, P601, DOI 10.1007/BF02550974

[8]

ARMBRUSTER DA, 1993, CLIN CHEM, V39, P181

[9] THE DISTRIBUTION OF PROSTATE SPECIFIC ANTIGEN IN MEN WITHOUT CLINICAL OR PATHOLOGICAL EVIDENCE OF PROSTATE-CANCER - RELATIONSHIP TO GLAND VOLUME AND AGE [J].

BABAIAN, RJ ;

MIYASHITA, H ;

EVANS, RB ;

RAMIREZ, EI .

JOURNAL OF UROLOGY, 1992, 147 (03) :837-840

[10] USING REPEATED-MEASURES OF SYMPTOM SCORE, UROFLOWMETRY AND PROSTATE-SPECIFIC ANTIGEN IN THE CLINICAL MANAGEMENT OF PROSTATE DISEASE [J].

BARRY, MJ ;

GIRMAN, CJ ;

OLEARY, MP ;

WALKERCORKERY, ES ;

BINKOWITZ, BS ;

COCKETT, ATK ;

GUESS, HA ;

HOLTGREWE, HL ;

MCCONNELL, JD ;

SIHELNIK, SA ;

MCLEOD, M ;

WINFIELD, HN ;

WILLIAMS, R .

JOURNAL OF UROLOGY, 1995, 153 (01) :99-103

← 1 2 3 4 5 6 7 8 9 10 →